Wanbangde Pharmaceutical Holding Group Co Ltd (002082) — Cash Flow Reinvestment Rate
Wanbangde Pharmaceutical Holding Group Co Ltd (002082) has a Cash Flow Reinvestment Rate of 2.60x as of June 2025, reinvesting CN¥159.76 Million (capex CN¥153.03 Million plus investments CN¥6.73 Million) from operating cash flow of CN¥61.33 Million. Explore 002082 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Wanbangde Pharmaceutical Holding Group Co Ltd Cash Flow Reinvestment Rate (2003–2025)
Historical reinvestment intensity for Wanbangde Pharmaceutical Holding Group Co Ltd across 18 annual periods. Also explore Wanbangde Pharmaceutical Holding Group C assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Wanbangde Pharmaceutical Holding Group Co Ltd (2003–2025)
Year-by-year capital reinvestment analysis for Wanbangde Pharmaceutical Holding Group Co Ltd. For live market cap and broader valuation context, see Wanbangde Pharmaceutical Holding Group C market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.49x | CN¥297.81 Million | CN¥603.98 Million | CN¥289.65 Million | ▼ -69.9% |
| 2024 | 1.64x | CN¥197.22 Million | CN¥120.22 Million | CN¥88.43 Million | ▼ -97.2% |
| 2021 | 57.80x | CN¥1.28 Billion | CN¥22.09 Million | CN¥277.06 Million | ▲ +1357.0% |
| 2020 | 3.97x | CN¥599.04 Million | CN¥151.01 Million | CN¥559.24 Million | ▲ +142.1% |
| 2018 | 1.64x | CN¥221.87 Million | CN¥135.40 Million | CN¥199.64 Million | ▲ +4926.7% |
| 2016 | 0.03x | CN¥10.13 Million | CN¥310.71 Million | CN¥9.03 Million | ▼ -98.2% |
| 2015 | 1.82x | CN¥30.47 Million | CN¥16.76 Million | CN¥30.47 Million | ▲ +467.9% |
| 2014 | 0.32x | CN¥44.91 Million | CN¥140.31 Million | CN¥44.91 Million | ▲ +502.5% |
| 2013 | 0.05x | CN¥12.45 Million | CN¥234.35 Million | CN¥12.45 Million | ▼ -73.7% |
| 2012 | 0.20x | CN¥40.92 Million | CN¥202.73 Million | CN¥40.92 Million | ▼ -25.6% |
| 2010 | 0.27x | CN¥44.02 Million | CN¥162.26 Million | CN¥44.02 Million | ▼ -69.2% |
| 2009 | 0.88x | CN¥60.02 Million | CN¥68.13 Million | CN¥60.02 Million | ▲ +51.7% |
| 2008 | 0.58x | CN¥146.92 Million | CN¥253.06 Million | CN¥146.92 Million | ▼ -93.4% |
| 2007 | 8.81x | CN¥109.68 Million | CN¥12.45 Million | CN¥109.68 Million | ▼ -67.0% |
| 2006 | 26.70x | CN¥93.47 Million | CN¥3.50 Million | CN¥93.47 Million | ▲ +241.2% |
| 2005 | 7.83x | CN¥87.86 Million | CN¥11.23 Million | CN¥87.86 Million | ▲ +160.2% |
| 2004 | 3.01x | CN¥98.30 Million | CN¥32.69 Million | CN¥98.30 Million | ▲ +193.5% |
| 2003 | 1.02x | CN¥37.92 Million | CN¥37.01 Million | CN¥37.92 Million | — |